Celldex Therapeutics, Inc. (NASDAQ:CLDX) has 184 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -54,173 | -0.98% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 2,279,605 | 39.30% | $0.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 0 | -157,549 | -2.58% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -134,612 | -35.88% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -54,619 | -1.10% | $0.00 |
| Bellevue Group AG | 31 Dec, 2025 | 0 | 60,000 | 1.69% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 441 | 2,321.05% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 72,817 | 1.84% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | -463,335 | -15.30% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 555,579 | 19.55% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | -99,262 | -4.96% | $0.00 |
| EVENTIDE ASSET MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -216,536 | -11.65% | $0.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 0 | 1,266,420 | 214.03% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -19,607 | -1.19% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | -2,135,585 | -54.84% | $0.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 0 | 237,510 | 24.36% | $0.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 0 | 280,805 | 24.33% | $0.00 |
| Novo Holdings A/S | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 1,184,092 | 1,081.94% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 38,671 | 3.76% | $0.00 |